Heart Failure Fact or Fiction: Preventing Heart Failure
A 70-year-old woman presents to the office for a preventive visit. She has a history of type 2 diabetes mellitus (T2DM) treated with metformin with recent hemoglobin A1c concentration 7.5%. She has a sister who was recently hospitalized for heart failure (HF). The patient has atherosclerotic cardiovascular disease (ASCVD) but does not have known HF.
Her N-terminal pro–B-type natriuretic peptide (NT-proBNP) level is measured and found to be 250 pg/mL. She asks what she can do to minimize her risk of developing HF.
The addition of empagliflozin to her regimen will reduce this patient's risk of cardiovascular death but not of hospitalization for HF.